As breast imaging continues to evolve toward more quantitative and patient-centred approaches, QT Imaging is developing a three-dimensional ultrasound platform designed to provide detailed breast imaging without ionising radiation, compressio... Read more
As AI and digital technologies increasingly influence pharmaceutical development, CDMOs are taking on a broader role in helping sponsors improve efficiency, manage risk and accelerate development timelines. In this interview, Matt Pat... Read more
Drug development is inherently uncertain, with scientific discoveries, manufacturing challenges, regulatory expectations and commercial priorities capable of reshaping a program at any stage. Rather than attempting to eliminate uncertainty, b... Read more
Bone Biologics is developing a targeted approach to bone regeneration through its proprietary NELL-1 platform, designed to address the limitations of conventional bone graft materials. In this interview with BioPharma Boardroom, Jef... Read more
Eisai Co., Ltd. and Biogen Inc., announced that once weekly lecanemab-irmb subcutaneous injection (brand name: LEQEMBI IQLIK®) is now available in the U.S. for initiation therapy for early Alzheimer’s disease (AD) in adults with mild cogn... Read more
In a major healthcare fraud enforcement action, Veloxis Pharmaceuticals will pay over million and accept a stringent deferred prosecution agreement after admitting illegal conduct tied to Envarsus XR in a case brought by two leading qui t... Read more
As AI and digital technologies increasingly influence pharmaceutical development, CDMOs are taking on a broader role in helping sponsors improve efficiency, manage risk and accelerate development timelines. In this interview, Matt Pat... Read more
PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, announced the upcoming availability of SPRQ-Nx chemistry and an accompanying software update for its Vega systems. Together, the updates expand the range o... Read more
© 2026 Biopharma Boardroom. All Rights Reserved.
